Erisyon
Erisyon is commercializing the world’s first single molecule protein sequencer
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Erisyon Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
grant
Raised Last:
$225k
Raised Total:$225k
Social
Metrics
4,611,259Website Global Rank
2,187Website Monthly Traffic
Twitter Followers
Description
Erisyon is commercializing the world’s first single molecule protein sequencer that promises to transform the way they detect, treat, and track disease. Inheriting over a decade of work performed at the University of Texas at Austin&s;s Center for Systems and Synthetic Biology, Erisyon was founded in March 2018 by a group of technologists and entrepreneurs with the ambition to usher in new discoveries that make the world healthier, safer, and more abundant.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2020 | Grant | 1 | $225k |
National Science Foundation National Science Foundation |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
